- Home
- BGM vs AXDX Comparison
BGM vs AXDX Comparison
Compare BGM & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- AXDX
- Stock Information
- Founded
- BGM 2019
- AXDX 1982
- Country
- BGM China
- AXDX United States
- Employees
- BGM N/A
- AXDX N/A
- Industry
- BGM
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- BGM
- AXDX Industrials
- Exchange
- BGM NYSE
- AXDX Nasdaq
- Market Cap
- BGM 309.0M
- AXDX 27.5M
- IPO Year
- BGM 2021
- AXDX 1996
- Fundamental
- Price
- BGM $9.20
- AXDX $1.08
- Analyst Decision
- BGM
- AXDX Hold
- Analyst Count
- BGM 0
- AXDX 1
- Target Price
- BGM N/A
- AXDX $1.00
- AVG Volume (30 Days)
- BGM 32.9K
- AXDX 84.4K
- Earning Date
- BGM 02-13-2025
- AXDX 11-07-2024
- Dividend Yield
- BGM N/A
- AXDX N/A
- EPS Growth
- BGM N/A
- AXDX N/A
- EPS
- BGM N/A
- AXDX N/A
- Revenue
- BGM N/A
- AXDX $11,909,000.00
- Revenue This Year
- BGM N/A
- AXDX $0.66
- Revenue Next Year
- BGM N/A
- AXDX $3.44
- P/E Ratio
- BGM N/A
- AXDX N/A
- Revenue Growth
- BGM N/A
- AXDX N/A
- 52 Week Low
- BGM $1.78
- AXDX $0.73
- 52 Week High
- BGM $14.78
- AXDX $3.05
- Technical
- Relative Strength Index (RSI)
- BGM 48.61
- AXDX 37.22
- Support Level
- BGM $8.80
- AXDX $1.06
- Resistance Level
- BGM $14.78
- AXDX $1.23
- Average True Range (ATR)
- BGM 1.04
- AXDX 0.12
- MACD
- BGM 0.05
- AXDX 0.01
- Stochastic Oscillator
- BGM 14.94
- AXDX 23.08
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.